회원게시판 > 사랑방 > (질문)임신4주라며 산부인과에서 혈압약 교체하라며 왔습니다.



라베타롤 11-09-05 17:06 2. 임신성 고혈압 성인 : 초회량으로 1회 100㎎ 1일 2회 투여한다. 필요한 경우 한 용량을 1주일 간격을 두고 증량하며 심한 경우 1일 3회까지 투여할 수 있다. 1일 최대 2400㎎을 초과해서는 안된다. 연령, 증상에 따라 적절히 증감한다. 2. 임신성 고혈압 성인 : 초회량으로 1회 100㎎ 1일 2회 투여한다. 필요한 경우 한 용량을 1주일 간격을 두고 증량하며 심한 경우 1일 3회까지 투여할 수 있다. 1일 최대 2400㎎을 초과해서는 안된다. 연령, 증상에 따라 적절히 증감한다.



트란데이트 11-09-05 17:26 라베타롤 상품명이 글락소 트란데이트인 데 생산중지되었습니다. 라베타롤 상품명이 글락소 트란데이트인 데 생산중지되었습니다.



CCB 11-09-05 17:07 제가 알기론, CCB로 통일되었을 겁니다. 아달라트서방정을 사용하고 있습니다. 제가 알기론, CCB로 통일되었을 겁니다. 아달라트서방정을 사용하고 있습니다.



해리슨 11-09-05 17:37 CHRONIC ESSENTIAL HYPERTENSION Pregnancy complicated by chronic essential hypertension is associated with intrauterine growth restriction and increased perinatal mortality. Pregnant women with chronic hypertension are at increased risk for superimposed preeclampsia and abruptio placenta. Women with chronic hypertension should have a thorough prepregnancy evaluation, both to identify remediable causes of hypertension and to ensure that the prescribed antihypertensive agents are not associated with adverse pregnancy outcome (e.g., ACE inhibitors, angiotensin-receptor blockers). a-Methyldopa and labetalol are the most commonly used medications for the treatment of chronic hypertension in pregnancy. Baseline evaluation of renal function is necessary to help differentiate the effects of chronic hypertension versus superimposed preeclampsia should the hypertension worsen during pregnancy. There are no convincing data that demonstrate that treatment of mild chronic hypertension improves perinatal outcome. Copyright?2001 McGraw-Hill. All rights reserved. CHRONIC ESSENTIAL HYPERTENSION Pregnancy complicated by chronic essential hypertension is associated with intrauterine growth restriction and increased perinatal mortality. Pregnant women with chronic hypertension are at increased risk for superimposed preeclampsia and abruptio placenta. Women with chronic hypertension should have a thorough prepregnancy evaluation, both to identify remediable causes of hypertension and to ensure that the prescribed antihypertensive agents are not associated with adverse pregnancy outcome (e.g., ACE inhibitors, angiotensin-receptor blockers). a-Methyldopa and labetalol are the most commonly used medications for the treatment of chronic hypertension in pregnancy. Baseline evaluation of renal function is necessary to help differentiate the effects of chronic hypertension versus superimposed preeclampsia should the hypertension worsen during pregnancy. There are no convincing data that demonstrate that treatment of mild chronic hypertension improves perinatal outcome. Copyright?2001 McGraw-Hill. All rights reserved.